SG11201805112WA - A method of manufacturing a vaginal ring - Google Patents

A method of manufacturing a vaginal ring

Info

Publication number
SG11201805112WA
SG11201805112WA SG11201805112WA SG11201805112WA SG11201805112WA SG 11201805112W A SG11201805112W A SG 11201805112WA SG 11201805112W A SG11201805112W A SG 11201805112WA SG 11201805112W A SG11201805112W A SG 11201805112WA SG 11201805112W A SG11201805112W A SG 11201805112WA
Authority
SG
Singapore
Prior art keywords
international
manufacturing
pct
vaginal ring
attachment part
Prior art date
Application number
SG11201805112WA
Other languages
English (en)
Inventor
Lasse Koivula
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55024875&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201805112W(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of SG11201805112WA publication Critical patent/SG11201805112WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D99/00—Subject matter not provided for in other groups of this subclass
    • B29D99/0082—Producing articles in the form of closed loops, e.g. rings
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2083/00—Use of polymers having silicon, with or without sulfur, nitrogen, oxygen, or carbon only, in the main chain, as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/24—Condition, form or state of moulded material or of the material to be shaped crosslinked or vulcanised
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2509/00—Use of inorganic materials not provided for in groups B29K2503/00 - B29K2507/00, as filler
    • B29K2509/08—Glass
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037—Other properties
    • B29K2995/0088—Molecular weight

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
SG11201805112WA 2015-12-21 2016-12-19 A method of manufacturing a vaginal ring SG11201805112WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15201507 2015-12-21
PCT/EP2016/081701 WO2017108671A1 (en) 2015-12-21 2016-12-19 A method of manufacturing a vaginal ring

Publications (1)

Publication Number Publication Date
SG11201805112WA true SG11201805112WA (en) 2018-07-30

Family

ID=55024875

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201805112WA SG11201805112WA (en) 2015-12-21 2016-12-19 A method of manufacturing a vaginal ring

Country Status (20)

Country Link
US (1) US20200276110A1 (es)
EP (1) EP3393450A1 (es)
JP (1) JP2019504021A (es)
KR (1) KR20180093255A (es)
CN (1) CN108472248A (es)
AR (1) AR107169A1 (es)
AU (1) AU2016375427A1 (es)
BR (1) BR112018012744A2 (es)
CA (1) CA3008940A1 (es)
CL (1) CL2018001692A1 (es)
CO (1) CO2018006394A2 (es)
HK (1) HK1254072A1 (es)
IL (1) IL259625A (es)
MX (1) MX2018007674A (es)
PE (1) PE20181431A1 (es)
RU (1) RU2018126790A (es)
SG (1) SG11201805112WA (es)
TW (1) TW201725243A (es)
UY (1) UY37044A (es)
WO (1) WO2017108671A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3075432C (en) * 2017-09-18 2023-05-23 Derek SHAM Methods and systems for vaginal therapeutic device fitting

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
CN1264488C (zh) * 2003-05-14 2006-07-19 上海市计划生育科学研究所 阴道环简易制备方法
DK2062569T3 (da) * 2007-11-22 2011-08-29 Bayer Oy Vaginalt afgivelsessystem
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
CA2713943C (en) * 2008-02-04 2018-10-23 Teva Women's Health, Inc. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
US20110280922A1 (en) * 2008-11-07 2011-11-17 Combinent Biomedical Systems, Inc. Devices and methods for treating and/or preventing diseases
US8580294B2 (en) * 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
TWI615155B (zh) * 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
AR089765A1 (es) * 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
US10137031B2 (en) * 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings

Also Published As

Publication number Publication date
RU2018126790A (ru) 2020-01-23
RU2018126790A3 (es) 2020-05-21
WO2017108671A1 (en) 2017-06-29
HK1254072A1 (zh) 2019-07-12
CA3008940A1 (en) 2017-06-29
TW201725243A (zh) 2017-07-16
US20200276110A1 (en) 2020-09-03
BR112018012744A2 (pt) 2018-12-04
IL259625A (en) 2018-07-31
CO2018006394A2 (es) 2018-07-10
MX2018007674A (es) 2018-09-12
AR107169A1 (es) 2018-03-28
UY37044A (es) 2017-07-31
JP2019504021A (ja) 2019-02-14
CN108472248A (zh) 2018-08-31
AU2016375427A1 (en) 2018-06-21
PE20181431A1 (es) 2018-09-12
EP3393450A1 (en) 2018-10-31
KR20180093255A (ko) 2018-08-21
CL2018001692A1 (es) 2018-10-05

Similar Documents

Publication Publication Date Title
SG11201811431VA (en) Multispecific antibodies against cd40 and cd137
SG11201807912SA (en) Vaccine against rsv
SG11201809912UA (en) Hybrid carriers for nucleic acid cargo
SG11201805120YA (en) Zika virus vaccine
SG11201901548SA (en) Anti-tim-3 antibodies and use thereof
SG11201808622SA (en) Chimeric receptors to flt3 and methods of use thereof
SG11201906431UA (en) Method for the treatment of thromboembolism
SG11201903021WA (en) Anti-human 4-1 bb antibodies and use thereof
SG11201808108XA (en) Synthesis of indazoles
SG11201807913XA (en) Stabilized soluble pre-fusion rsv f proteins
SG11201908971RA (en) Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene
SG11201909963YA (en) Methods for treating dravet syndrome
SG11201806342SA (en) Glucagon and glp-1 co-agonists for the treatment of obesity
SG11201805950UA (en) Self-assembled nanostructures and separation membranes comprising aquaporin water channels and methods of making and using them
SG11201408092UA (en) Endoprosthesis and delivery device for implanting such endoprosthesis
SG11201907804QA (en) Pharmaceutical composition comprising selexipag
SG11201901996UA (en) Formulations of ( r)-2-amino-3-phenylpropyl carbamate
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201804916PA (en) Three-dimensional polymer networks with channels situated therein
SG11201805001UA (en) Method of treating influenza a
SG11201810429UA (en) Anti-cd19 antibody formulations
SG11201810078PA (en) Stabilized pre-fusion rsv f proteins
SG11201808686VA (en) Synthesis of indazoles
SG11201908275XA (en) Peptides and methods for the treatment of diabetes
SG11201805755SA (en) Methods of administering hepcidin